Company news
Jianmin Pharmaceutical Group Co Ltd. news in 2026
Jianmin Pharmaceutical Group Co Ltd.'s news releases, calls and decks from 2026, newest first.
(600976)"Jianmin Pharmaceutical Group Co., Ltd."Report for Q3 2026
October 21, 2026
(600976)"Jianmin Pharmaceutical Group Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing
October 16, 2026
Announcement on Approval for Marketing of Crisaborole Ointment
September 3, 2026
Semi-annual Report for 2026
August 19, 2026
Announcement on Convening the 2026 Semi-annual Performance Briefing
August 17, 2026
Announcement on Inclusion of the Company's Products in the "National Essential Medicines List"
July 9, 2026
Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction
July 1, 2026
Announcement on Obtaining Notice of Approval for Drug Clinical Trials
June 30, 2026
Announcement on Implementation of Dividend Distribution for 2025
April 20, 2026
Announcement on Resolutions of the 8th Meeting of the 11th Board of Directors
April 17, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
April 10, 2026
Announcement on Resolutions of the 7th Meeting of the 11th Board of Directors
March 20, 2026
Announcement on Convening the 2025 Annual Performance Briefing
March 16, 2026
Announcement on Resolutions of the 6th Meeting of the 11th Board of Directors
January 23, 2026